Stay updated on SAGE-547 in Severe Postpartum Depression Clinical Trial
Sign up to get notified when there's something new on the SAGE-547 in Severe Postpartum Depression Clinical Trial page.

Latest updates to the SAGE-547 in Severe Postpartum Depression Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedAdded the Lancet 2018 primary publication on brexanolone in postpartum depression and removed the related erratum reference.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check33 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check61 days agoChange DetectedAdded Revision: v3.4.2; removed the funding-status notice about a lapse in government funding and Revision: v3.4.1.SummaryDifference0.3%

- Check68 days agoChange DetectedA government funding notice was added, and the Publications section gained a new Lancet article on postpartum depression while removing the previous Lancet citation.SummaryDifference0.4%

- Check75 days agoChange DetectedThe page now shows a Show glossary option and updated metadata: Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and Revision: v3.4.0; the previous items Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4 were removed.SummaryDifference0.2%

Stay in the know with updates to SAGE-547 in Severe Postpartum Depression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SAGE-547 in Severe Postpartum Depression Clinical Trial page.